Medications for Alcohol Use Disorder: How They Reduce Relapse Risk - and When They Don’t

Medications for Alcohol Use Disorder: How They Reduce Relapse Risk - and When They Don’t

Medications for Alcohol Use Disorder: How They Reduce Relapse Risk - and When They Don’t

Nov, 26 2025 | 3 Comments

When someone is trying to stop drinking, the hardest part isn’t always willpower - it’s the brain’s constant pull back toward alcohol. That’s where medications come in. For people with Alcohol Use Disorder (AUD), drugs like naltrexone, acamprosate, and disulfiram aren’t magic pills, but they do change the odds. Studies show they can cut relapse risk by 18% to 30%, depending on the person and the drug. Yet, only about 1 in 10 people with AUD in the U.S. even get prescribed one. Why? Because many don’t know how they work - or when they might make things worse.

How These Medications Actually Work

Each of the three FDA-approved medications for AUD targets a different part of the addiction cycle. They don’t cure alcohol dependence, but they help manage it - like insulin for diabetes.

Naltrexone blocks the brain’s opioid receptors. When you drink, alcohol normally triggers a dopamine surge that makes you feel good. Naltrexone dulls that reward. You still drink, but it doesn’t feel as satisfying. That reduces heavy drinking episodes. A 2021 meta-analysis of nearly 3,000 people found oral naltrexone (50 mg daily) cut relapse risk by 18% compared to placebo. The monthly shot, Vivitrol, works the same way but doesn’t require daily pills.

Acamprosate works after you’ve stopped drinking. Heavy alcohol use scrambles brain chemicals like GABA and glutamate. When you quit, your brain stays out of balance, causing anxiety, restlessness, and insomnia - big triggers for relapse. Acamprosate helps stabilize those systems. It’s most effective for people who’ve already detoxed and are aiming for total abstinence. In clinical trials, it improved abstinence rates by about 15% over six months.

Disulfiram is the oldest and most dramatic. It makes your body react badly to alcohol. If you drink while taking it, you get intense flushing, nausea, vomiting, and a dangerous drop in blood pressure. It’s a deterrent - a physical warning sign that says, “Don’t even think about it.” But it only works if you take it consistently. And if you forget? The risk isn’t just a bad hangover - it’s a medical emergency.

Which Medication Is Right for You?

There’s no one-size-fits-all. The best choice depends on your goals, your body, and your history.

If you’re trying to cut back on heavy drinking - maybe you’re not ready to quit completely - naltrexone is often the first pick. It doesn’t force abstinence. It just makes drinking less rewarding. People who’ve tried to quit before and kept falling back into binge patterns tend to respond well.

If you’ve already stopped drinking and want to stay stopped, acamprosate is the go-to. It helps with the emotional chaos that follows detox: the jitteriness, the irritability, the urge to drink just to feel normal. But here’s the catch: you can’t start it until you’ve been alcohol-free for at least 3 to 5 days. If you’re still drinking, it won’t help - and might even make you sick.

Disulfiram is for a very specific type of person: highly motivated, with strong social support, and willing to live with the consequences of a slip-up. It’s not for someone who drinks occasionally or is unsure about quitting. One study showed 28% of people quit disulfiram because of side effects like metallic taste, drowsiness, or fear of accidentally drinking something with alcohol - like mouthwash or cough syrup.

There’s also gabapentin, not FDA-approved for AUD but widely used off-label. It’s especially helpful for people who’ve had severe withdrawal symptoms - seizures, hallucinations, delirium tremens. A 2020 trial found 45% of high-risk patients stayed abstinent on gabapentin, compared to 28% on placebo. It’s also safer for people with liver disease, since it’s cleared by the kidneys, not the liver.

Why So Many People Stop Taking These Drugs

The data is clear: these medications work. But real life is messier.

In clinical trials, about 60% of people stick with naltrexone or acamprosate for 16 weeks. In the real world? Only 35% are still taking them after three months. Why?

  • Side effects: Nausea is common with naltrexone. Diarrhea and dizziness happen with acamprosate. Disulfiram causes fatigue and a bad taste in the mouth.
  • Cost: Even though most are available as generics, monthly costs can hit $200-$400. Insurance doesn’t always cover them, and copays add up fast.
  • Timing: You can’t start acamprosate until you’ve stopped drinking. If you’re still using, you’re stuck waiting - and that waiting period is when most people slip back.
  • Expectations: Many think medication will make the craving disappear. It doesn’t. It just makes drinking less appealing. If you’re expecting a miracle, you’ll be disappointed.

One patient told a recovery forum: “I took naltrexone for two months. I didn’t get drunk, but I still drank every night. It didn’t make me stop - just made me feel weird.” That’s not failure. That’s how it works. The goal isn’t to feel nothing. It’s to reduce the damage.

A person at a kitchen table with three AUD medication bottles and a glass of wine with a red X.

What Happens When You Mix Medication With Alcohol

This is where things get dangerous.

With disulfiram, drinking even a small amount of alcohol - a sip of wine, a beer, or a dessert with alcohol - can trigger a life-threatening reaction. Blood pressure can crash. Heart rhythm can go haywire. Emergency rooms see this often.

With naltrexone, drinking isn’t physically dangerous, but it defeats the purpose. You’ll still get the physical effects of alcohol - impaired coordination, poor judgment - but you won’t feel the usual reward. That can lead to risky behavior: “I’m on naltrexone, so I’ll have more.” That increases the chance of injury or overdose.

With acamprosate, alcohol doesn’t cause a bad reaction. But if you drink while taking it, the medication doesn’t work. It’s like taking insulin and then eating a whole cake - the drug can’t fix what you’re actively breaking.

And then there’s liver damage. Naltrexone is processed by the liver. If you have cirrhosis or hepatitis, it can build up and cause toxicity. Doctors check liver enzymes before and during treatment. Acamprosate is cleared by the kidneys - so if you have kidney disease, your dose must be lowered. Gabapentin is safer here, which is why it’s becoming a top choice for people with alcohol-related liver disease.

Why So Few Doctors Prescribe These Drugs

You might think, “If they work, why isn’t everyone on them?” The answer is simple: most doctors don’t know how to use them.

A 2023 survey found only 28% of primary care doctors in the U.S. feel confident prescribing AUD medications. Many still think addiction treatment belongs only in rehab centers or specialty clinics. But AUD is a medical condition - like high blood pressure or diabetes. It should be treated in the same place you go for your annual checkup.

Doctors also worry about liability. If someone on disulfiram drinks and ends up in the ER, who’s responsible? If a patient on naltrexone keeps drinking and loses their job, did the doctor enable it?

But the bigger problem is stigma. Addiction is still seen as a moral failure, not a brain disease. That’s changing - slowly. More medical schools now teach addiction medicine. More insurance plans are covering AUD meds. But progress is uneven.

Doctor and patient reviewing a brain scan with emerging AUD treatment icons in a modern clinic.

What’s Next: New Treatments and Personalized Care

The field is moving fast.

Researchers are using brain scans to predict who will respond to which drug. One study found that people with higher white matter integrity in the frontal brain region were 68% more likely to respond to acamprosate. That means one day, we might test your brain before prescribing.

New drugs are coming. A combination of buprenorphine and samidorphan reduced heavy drinking days by 32% in a 2023 trial. Ketamine infusions showed a 41% drop in relapse. Even probiotics and anti-inflammatory agents are being tested, because gut health is linked to cravings.

Longer-acting forms are also in development. A 6-month naltrexone implant is in phase 2 trials. If it works, adherence could jump from 42% (with monthly shots) to 78%. That’s huge.

And digital tools are helping. Apps that track cravings, send reminders, and connect you to peer support have been shown to cut relapse risk by a third when used with medication.

What You Can Do Right Now

If you or someone you know is struggling with alcohol:

  • Don’t wait for “rock bottom.” Medications work best when started early.
  • Ask your doctor about naltrexone or acamprosate. They’re safer and more effective than you think.
  • If you’ve had withdrawal symptoms before, ask about gabapentin.
  • If you’re considering disulfiram, make sure you have strong support - and understand the risks.
  • Don’t stop taking the medication just because you feel fine. Most people relapse within months of quitting.
  • Combine medication with counseling. No pill works alone.

Alcohol Use Disorder isn’t a character flaw. It’s a medical condition with proven treatments. The fact that so few people get them isn’t because the treatments don’t work. It’s because we still don’t treat addiction like the disease it is.

Can I drink alcohol while taking naltrexone?

Yes, you can - but it defeats the purpose. Naltrexone blocks the pleasurable effects of alcohol, so drinking becomes less rewarding. But it doesn’t protect you from alcohol’s physical harm - impaired judgment, liver damage, or overdose risk. Some people drink more to overcome the block, which increases danger. The goal is to reduce drinking, not to drink heavily while medicated.

How long should I take AUD medications?

Most guidelines recommend 6 to 12 months. But for many people, AUD is a chronic condition - like hypertension or asthma. Stopping too soon increases relapse risk. Some patients stay on naltrexone or acamprosate for years. The key is to work with your doctor to decide when it’s safe to taper, not to quit on your own.

Why isn’t disulfiram used more often?

Because it’s hard to use safely. The reaction to alcohol can be severe - even life-threatening. Patients often stop taking it because of side effects like drowsiness or a bad taste. Compliance is low, and studies on its effectiveness have methodological flaws. It’s only recommended for highly motivated patients with strong support systems - not for most people.

Can I take these medications if I have liver disease?

It depends. Naltrexone is processed by the liver, so it’s risky if you have cirrhosis or active hepatitis. Acamprosate is cleared by the kidneys, so it’s safer for liver disease - but kidney function must be checked. Gabapentin is often preferred in these cases because it doesn’t stress the liver. Always get liver tests before starting any medication.

Are there any new medications for AUD on the horizon?

Yes. A 6-month naltrexone implant is in late-stage trials and could improve adherence dramatically. A combination drug called ALKS 5461 reduced heavy drinking by 32% in a 2023 trial. Ketamine infusions and gut-targeted therapies like probiotics are also showing promise. These aren’t available yet, but they’re coming fast - and they’re based on real science, not hype.

Do these medications help with cravings?

Naltrexone reduces cravings by blocking the brain’s reward system. Acamprosate helps by calming brain activity after withdrawal, which lowers the emotional urge to drink. Gabapentin reduces anxiety-related cravings, especially in people with a history of severe withdrawal. No medication eliminates cravings completely - but they can make them manageable.

If you’ve tried to quit drinking before and failed, don’t give up. The problem isn’t you - it’s that you haven’t found the right tool yet. Medications for AUD aren’t perfect, but they’re the most effective option we have. And they work best when you’re not alone.

About Author

Oliver Bate

Oliver Bate

I am a passionate pharmaceutical researcher. I love to explore new ways to develop treatments and medicines to help people lead healthier lives. I'm always looking for ways to improve the industry and make medicine more accessible to everyone.

Comments

Savakrit Singh

Savakrit Singh November 26, 2025

Interesting breakdown, but let’s be real - most of these meds are just fancy placebos with side effects. 🤷‍♂️ Naltrexone? Makes you feel like a zombie. Acamprosate? Costs more than my rent. And disulfiram? That’s not treatment, that’s punishment. We need better options, not more chemical handcuffs. 💊😭

Cecily Bogsprocket

Cecily Bogsprocket November 28, 2025

I’ve been on naltrexone for 14 months now. It didn’t make me ‘cured,’ but it made me stop needing to drink to feel okay. The craving didn’t vanish - it just lost its scream. I still have bad days. But now I have space to choose. That’s everything.

It’s not about willpower. It’s about rewiring. And this isn’t a moral failure. It’s neurobiology. We treat diabetes with insulin - why are we still whispering about AUD?

Also, gabapentin changed my life. No more night terrors. No more trembling hands at 3 a.m. If you’ve had withdrawal, ask your doctor. Don’t wait until you’re broken.

And yes - it’s okay to stay on it for years. No shame. No rush. Healing isn’t a sprint.

Thank you for writing this. So many people need to hear it.

Jebari Lewis

Jebari Lewis November 28, 2025

Wait - you’re telling me doctors don’t know how to prescribe these? That’s absurd. We have peer-reviewed meta-analyses, FDA approvals, and clinical guidelines - yet primary care physicians are still treating addiction like it’s a 1950s moral dilemma?

This isn’t just negligence. It’s systemic failure. We train doctors to manage hypertension, but when someone’s brain chemistry is hijacked by alcohol? They get shrugged off.

And don’t get me started on insurance. Why is naltrexone a $300 copay when metformin is $4? This is healthcare apartheid.

Also - gabapentin for liver patients? Brilliant. Why isn’t this first-line? The data’s there. The safety profile’s better. Why are we still clinging to disulfiram like it’s a medieval exorcism?

We need mandatory addiction training in med school. Not optional. Not ‘if you’re interested.’ Required. Like CPR.

Write a comment